Evidence map›Paper›PMID 40213675›Full record

ArticleTheranostics2025

A self-healing radiopaque hyaluronic acid hydrogel as a new injectable biomaterial for precision medicine in osteoarthritis.

Moustoifa Said, Clément Tavakoli, Chloé Dumot, Karine Toupet, Cécile Olivier, Alexia Gilles, Marie Maumus, Yuxi Clara Dong, Nora Collomb, Céline Auxenfans and 12 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Theranostics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Moustoifa SaidUniv. Grenoble Alpes, Centre de Recherches sur les Macromolécules Végétales (CERMAV-CNRS), 38041 Grenoble, France.
Clément TavakoliUniv. Lyon 1, Inserm U1060, CarMeN Laboratory, 69600 Oullins, France.
Chloé DumotUniv. Lyon 1, Inserm U1060, CarMeN Laboratory, 69600 Oullins, France.
Karine ToupetIRMB, Univ. Montpellier, INSERM, CHU Montpellier, 34295 Montpellier, France.
Cécile OlivierUniv. Grenoble Alpes, Inserm, UA7 Strobe, 38000 Grenoble, France.
Alexia GillesIRMB, Univ. Montpellier, INSERM, CHU Montpellier, 34295 Montpellier, France.
Marie MaumusIRMB, Univ. Montpellier, INSERM, CHU Montpellier, 34295 Montpellier, France.
Yuxi Clara DongDepartment of Radiology and Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Nora CollombUniv. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Céline AuxenfansHôpital Edouard Herriot, 69003 Lyon, France.
Anaïck MoisanCell Therapy and Engineering Unit, EFS Rhône Alpes, 38330 Saint Ismier, France.
Bertrand FavierUniv. Grenoble Alpes, Translational Innovation in Medicine & Complexity, UMR552, 38700 La Tronche, France.
Benoit ChovelonUniv. Grenoble-Alpes, Département de Pharmacochimie Moléculaire UMR 5063, 38400 Grenoble, France.
Emmanuel Luc BarbierUniv. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France.
David Peter CormodeDepartment of Radiology and Department of Bioengineering, University of Pennsylvania, Philadelphia, Pennsylvania 19104, United States.
Emmanuel BrunUniv. Grenoble Alpes, Inserm, UA7 Strobe, 38000 Grenoble, France.
Hélène ElleaumeUniv. Grenoble Alpes, Inserm, UA7 Strobe, 38000 Grenoble, France.
Marlène WiartUniv. Lyon 1, Inserm U1060, CarMeN Laboratory, 69600 Oullins, France.
Olivier DetanteUniv. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Claire RomeUniv. Grenoble Alpes, Inserm, U1216, Grenoble Institut Neurosciences, 38000 Grenoble, France.
Danièle NoëlIRMB, Univ. Montpellier, INSERM, CHU Montpellier, 34295 Montpellier, France.
Rachel Auzély-VeltyUniv. Grenoble Alpes, Centre de Recherches sur les Macromolécules Végétales (CERMAV-CNRS), 38041 Grenoble, France.

Funding

Renally clearable ytterbium nanoparticle contrast agents for spectral photon counting computed tomographyR21EB030373 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI CORMODE, DAVID PETER · 2021 to 2022
$447k
Tumor casting hydrogels for interventional radiology treatment of hepatocellular carcinomaR21EB029556 · NIBIB · UNIVERSITY OF PENNSYLVANIA · PI CORMODE, DAVID PETER · 2021 to 2022
$447k
NIBIB NIH HHS R21 EB029556NIBIB NIH HHS R21 EB030373
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biocompatible MaterialsContrast MediaHyaluronic AcidHydrogelsOsteoarthritisOsteoarthritis, KneePrecision MedicineAnimalsDisease Models, AnimalHumansInjections, Intra-ArticularMiceViscosupplementationBiocompatible MaterialsContrast MediaHyaluronic AcidHydrogelshyaluronic acidInjectable hydrogelIodineviscosupplementationX-ray

Identifiers

PMID40213675
PMCPMC11980665

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.